These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9747664)

  • 1. Harmonising adverse drug reaction terminology: the role of the Council for International Organizations of Medical Sciences.
    Venulet J; Bankowski Z
    Drug Saf; 1998 Sep; 19(3):165-72. PubMed ID: 9747664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International reporting on adverse drug reactions: the CIOMS project. CIOMS ADR Working Group.
    Faich GA; Castle W; Bankowski Z
    Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):133-8. PubMed ID: 2338366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring drug safety in Astrakhan, Russia.
    Kirilochev OO; Dorfman IP; Umerova AR
    Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced liver disorders: report of an international consensus meeting.
    Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):317-22. PubMed ID: 2272712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishing requirements for the use of terms for reporting adverse drug reactions.
    Venulet J
    Int J Clin Pharmacol Res; 1992; 12(2):61-4. PubMed ID: 1428299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse drug reactions of non-opioid and opioid analgesics reported to Croatian national authority from 2007 to 2014.
    Sunara P; Krnic D; Puljak L
    Acta Med Acad; 2017 Nov; 46(2):94-104. PubMed ID: 29338273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Points of view on adverse drug reactions terminology.
    Benichou C; Castle W
    Therapie; 1998; 53(2):145-9. PubMed ID: 9773114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse drug reactions in the paediatric population in Denmark: a retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007.
    Aagaard L; Weber CB; Hansen EH
    Drug Saf; 2010 Apr; 33(4):327-39. PubMed ID: 20297864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [International reporting of adverse drug reactions. Final report of CIOMS ADR Working Group].
    Royer RJ; Benichou C
    Therapie; 1991; 46(3):173-8. PubMed ID: 1792648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How do pharmaceutical companies handle consumer adverse drug reaction reports? An overview based on a survey of French drug safety managers and officers.
    Fleuranceau-Morel P
    Pharmacoepidemiol Drug Saf; 2002; 11(1):37-44. PubMed ID: 11998550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methods and systems to detect adverse drug reactions in hospitals.
    Thürmann PA
    Drug Saf; 2001; 24(13):961-8. PubMed ID: 11735652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Work of the Council for International Organizations of Medical Sciences (CIOMS) in Global Pharmacovigilance.
    Younus MM; Zweygarth M; Rägo L; Harrison-Woolrych M
    Drug Saf; 2020 Nov; 43(11):1067-1071. PubMed ID: 33034859
    [No Abstract]   [Full Text] [Related]  

  • 14. [The international system of drug control].
    Barbadoro E
    Boll Chim Farm; 1990 Mar; 129(3):140-3. PubMed ID: 2245002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishing requirements for the use of terms for reporting adverse drug reactions (ADR). Consultant, Council for International Organizations of Medical Sciences (CIOMS), World Health Organization.
    Mater Med Pol; 1993; 25(1):45-6. PubMed ID: 8412342
    [No Abstract]   [Full Text] [Related]  

  • 16. Supervised signal detection for adverse drug reactions in medication dispensing data.
    Hoang T; Liu J; Roughead E; Pratt N; Li J
    Comput Methods Programs Biomed; 2018 Jul; 161():25-38. PubMed ID: 29852965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of a changed legislation on reporting of adverse drug reactions in Sweden, with focus on nurses' reporting.
    Karlsson SA; Jacobsson I; Boman MD; Hakkarainen KM; Lövborg H; Hägg S; Jönsson AK
    Eur J Clin Pharmacol; 2015 May; 71(5):631-6. PubMed ID: 25845655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain.
    Sweis D; Wong IC
    Drug Saf; 2000 Aug; 23(2):165-72. PubMed ID: 10945377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse drug reaction monitoring in a secondary care hospital in South India.
    Arulmani R; Rajendran SD; Suresh B
    Br J Clin Pharmacol; 2008 Feb; 65(2):210-6. PubMed ID: 17662089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the WHO programme on International Drug Monitoring in coordinating worldwide drug safety efforts.
    Olsson S
    Drug Saf; 1998 Jul; 19(1):1-10. PubMed ID: 9673854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.